411-调节性T细胞治疗:从免疫耐受到组织修复 episode artwork

EPISODE · Jan 21, 2026 · 21 MIN

411-调节性T细胞治疗:从免疫耐受到组织修复

from 聊聊Sci

这项前瞻性综述系统阐述了调节性T细胞(Treg)在生物学机制与临床转化方面的最新进展。文章深入探讨了Treg维持免疫耐受、促进组织修复及通过代谢重编程适应微环境的核心能力。作者强调,通过低剂量IL-2疗法、过继性Treg移植及CAR-Treg等前沿技术,该领域正经历从单纯的免疫抑制向精准免疫重建的模式转变。研究特别关注了Treg在治疗自身免疫病和神经退行性疾病(如阿尔茨海默病、肌萎缩侧索硬化症)中的潜力。尽管在细胞生产规模、 lineage稳定性及长期安全性方面仍面临挑战,但Treg作为“活药”为实现疾病长期缓解提供了新路径。该综述最终为开发下一代精准免疫公差策略制定了整合基础研究与临床洞察的路线图。References: Zou, Chengyu et al. Next steps in regulatory T cells: Biology and clinical application. Cell, Volume 189, Issue 1, 6 - 22前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Jan 21, 2026

Embed this episode

Ready to play

411-调节性T细胞治疗:从免疫耐受到组织修复

0:00 21:32

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 21 minutes long.

When was this 聊聊Sci episode published?

This episode was published on January 21, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!